News LCT completes treatment phase of their pre-clinical study to treat diabetes Living Cell Technologies announced that the Company has completed the transplantation of its DiaBCell diabetes product in what it believes is the world’s largest controlled diabetic primate pre-clinical study of its kind. Related Document |